ASHLAND INC. (ASH) earnings date

NYSE · Mid cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 30 days, typically, give or take 3 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q4 FY2026Tue, Nov 3, 2026after close 34 8-K
Q3 FY2026Tue, Jul 28, 2026after close 28 8-K
Q2 FY2026Tue, Apr 28, 2026after close 28 8-K
Q1 FY2026Mon, Feb 2, 2026after close 33 8-K
Q4 FY2025Tue, Nov 4, 2025after close 35 8-K
Q3 FY2025Tue, Jul 29, 2025after close 29 8-K
Q2 FY2025Wed, Apr 30, 2025after close 30 8-K
Q1 FY2025Tue, Jan 28, 2025after close 28 8-K

What they guided beta

Q4 FY2026 "Ashland reports fourth quarter and full-year fiscal 2026 results and issues outlook for fiscal 2027" exhibit
Q4 FY2026 "Issues outlook for full‑year fiscal 2027 sales of $1,905-$1,975 million and Adjusted EBITDA of $405-$435 million WILMINGTON, Del., November 3, 2026 – Ashland Inc. (NYSE: ASH) today announced financial results 1 for the fourth quarter of fiscal year 2026, which ended September 30, 2026, together with its fiscal year 2026 results summary and full-year fiscal 2027 outlook." exhibit
Q4 FY2026 "Financial Outlook Ashland is issuing the following guidance for fiscal 2027, reflecting its current expectations for market conditions, business performance and continued execution of its strategic priorities." exhibit
Q4 FY2026 "Full-year fiscal 2027 guidance" exhibit
Q4 FY2026 "Pricing and input costs: raw material and freight costs are expected to remain volatile during fiscal 2027, with pricing actions expected to offset anticipated inflation." exhibit
Q3 FY2026 "Ashland reports third quarter 2026 results and reaffirms full-year sales & Adjusted EBITDA outlook" exhibit
Q3 FY2026 "Reaffirming full‑year fiscal 2026 sales guidance of $1,835-$1,870 million and Adjusted EBITDA guidance of $385-$400 million WILMINGTON, Del., July 28, 2026 – Ashland Inc. (NYSE: ASH) today announced financial results 1 for the third quarter of fiscal year 2026, which ended June 30, 2026, and reaffirmed its full-year fiscal 2026 sales and Adjusted EBITDA outlook." exhibit
Q3 FY2026 "Adjusted EBITDA was $109 million, representing a 21.9 percent margin, down four percent from $113 million in the prior-year quarter, as favorable volumes and pricing actions were more than offset by the lingering impact of lower production rates experienced earlier in the fiscal year, inflationary cost pressures, and the normalization of incentive compensation from a low prior-year base." exhibit
Q3 FY2026 "Financial Outlook Ashland is reaffirming its full year fiscal 2026 sales guidance of $1,835 to $1,870 million and its Adjusted EBITDA guidance of $385 to $400 million." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/ASH
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/ASH

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

ASH earnings date badge

HTML

<a href="https://veritasdata.dev/company/ASH/"><img src="https://veritasdata.dev/embed/ASH.svg" alt="ASH earnings date" width="240" height="56"></a>

Markdown

[![ASH earnings date](https://veritasdata.dev/embed/ASH.svg)](https://veritasdata.dev/company/ASH/)

Script

<script async src="https://veritasdata.dev/embed/ASH.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/ASH"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.